Biodexa Pharmaceuticals (BDRX) Dividends Paid - Common (2019 - 2022)
Biodexa Pharmaceuticals (BDRX) posted Dividends Paid - Common of $7.5 million for Q4 2022, down 5.16% sequentially from $7.9 million in Q3 2022, and up 32.94% YoY from $5.7 million in Q4 2021.
Biodexa Pharmaceuticals (BDRX) Dividends Paid - Common (2019 - 2022) Analysis & Trends
Biodexa Pharmaceuticals has reported Dividends Paid - Common for 4 years, with the latest figure at $7.5 million in Q4 2022.
- Quarterly Dividends Paid - Common rose 32.94% year-over-year to $7.5 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $27.0 million (up 19.02% YoY) and the FY2022 annual result came in at $7.9 million, up 37.43% from the prior year.
- Dividends Paid - Common slipped to $7.5 million in Q4 2022 per BDRX's latest filing, from $7.9 million in the prior quarter.
- Over five years, Dividends Paid - Common peaked at $11.5 million in Q4 2019 and troughed at $5.5 million in Q3 2020.
- A 4-year average of $7.1 million and a median of $5.8 million in 2021 frame the typical range for Dividends Paid - Common.
- The sharpest annual moves came in 2020 and 2022: Dividends Paid - Common tumbled 50.48% in 2020, then jumped 35.99% in 2022.
- Over 4 years, Dividends Paid - Common stood at $11.5 million in 2019, then sank by 50.48% to $5.7 million in 2020, then fell by 0.84% to $5.7 million in 2021, then jumped by 32.94% to $7.5 million in 2022.
- According to Business Quant data, Dividends Paid - Common over the past three periods registered $7.5 million, $7.9 million, and $5.7 million for Q4 2022, Q3 2022, and Q4 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 34.60 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Biodexa Pharmaceuticals | 63,168.17 | -11.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 7.53 Mn |
| Dec 31, 2022 | 7.53 Mn |
| Sep 14, 2022 | 7.94 Mn |
| Sep 14, 2022 | 7.94 Mn |
| Dec 31, 2021 | 5.67 Mn |
| Dec 31, 2021 | 5.67 Mn |
| Sep 17, 2021 | 5.84 Mn |
| Sep 17, 2021 | 5.84 Mn |
| Dec 31, 2020 | 5.71 Mn |
| Dec 31, 2020 | 5.71 Mn |
| Sep 10, 2020 | 5.45 Mn |
| Sep 10, 2020 | 5.45 Mn |
| Dec 31, 2019 | 11.54 Mn |
| Dec 31, 2019 | 11.54 Mn |